Mechanisms related to the pathophysiology and management of central hypothyroidism.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 18941435)

Published in Nat Clin Pract Endocrinol Metab on October 21, 2008

Authors

Masanobu Yamada1, Masatomo Mori

Author Affiliations

1: Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan. myamada@med.gunma-u.ac.jp

Articles by these authors

(truncated to the top 100)

Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19

Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol (2004) 2.88

Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid (2012) 2.78

Endoscopic treatment of rectal carcinoid tumors. Dis Colon Rectum (2010) 2.01

Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology (2007) 1.82

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Mol Cancer Ther (2011) 1.74

Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 1.66

Functional gastrointestinal disorders in adolescents and quality of school life. J Gastroenterol Hepatol (2013) 1.50

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy. Lung Cancer (2007) 1.48

Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy. World J Gastroenterol (2006) 1.45

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest (2007) 1.41

Usefulness of cholescintigraphy with lipid meal loading for diagnosis and determination of cholecystectomy in a patient with gallbladder dysfunction. Intern Med (2004) 1.39

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci (2008) 1.37

Primary amenorrhea accompanied by adrenal adenoma: start of menarche soon after tumor resection. Intern Med (2002) 1.37

Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun (2008) 1.33

Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun (2002) 1.32

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci (2007) 1.31

Stricture after endoscopic submucosal dissection for early gastric cancers and adenomas. Dig Endosc (2010) 1.28

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res (2005) 1.27

Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology (2004) 1.24

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer. Lung Cancer (2007) 1.23

Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol (2006) 1.23

Barium sulphate aspiration. Lancet (2004) 1.21

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res (2010) 1.20

Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: case report and literature review. World J Gastroenterol (2006) 1.20

Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab (2012) 1.17

Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol (2006) 1.16

Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure. Intern Med (2010) 1.14

Endoscopic management of duodenal diverticular bleeding. Gastrointest Endosc (2007) 1.14

Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J Cell Biol (2005) 1.11

A new anorexigenic protein, nesfatin-1. Peptides (2009) 1.09

C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol (2003) 1.09

Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) (2010) 1.08

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Int J Cancer (2011) 1.08

Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. Diabetes (2008) 1.08

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene (2002) 1.07

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res (2007) 1.07

CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol (2009) 1.07

Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene (2002) 1.06

Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet β-cells. Endocr J (2011) 1.05

Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol (2007) 1.05

Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol (2007) 1.04

A case of amebic liver abscess complicated by hemobilia due to rupture of hepatic artery aneurysm. Hepatogastroenterology (2002) 1.04

Clinical characteristics and treatment for patients presenting with bleeding duodenal varices. Dig Endosc (2010) 1.04

The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol (2007) 1.04

Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology (2006) 1.03

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer. Lung Cancer (2009) 1.02

Cytokines and STATs in Liver Fibrosis. Front Physiol (2012) 1.02

Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. Immunol Lett (2002) 1.02

c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J Immunol (2003) 1.01

Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab (2011) 1.01

Primary mediastinal synovial sarcoma: a report of 2 cases. J Comput Assist Tomogr (2008) 1.01

Analysis of colonoscopic perforations at a local clinic and a tertiary hospital. World J Gastroenterol (2012) 1.01

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis (2009) 1.01

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis. Clin Nucl Med (2007) 1.01

Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci (2003) 1.01

Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem (2005) 1.00

Nesfatin-1: an overview and future clinical application. Endocr J (2009) 1.00

Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun (2009) 1.00

Tyrosine phosphorylation of Munc18c regulates platelet-derived growth factor-stimulated glucose transporter 4 translocation in 3T3L1 adipocytes. Endocrinology (2007) 1.00

Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) (2010) 1.00

Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J Biol Chem (2002) 0.99

Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci (2007) 0.99

CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. J Biol Chem (2008) 0.99

Forearm muscle metastasis as an initial clinical manifestation of lung cancer. South Med J (2009) 0.99

Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int (2006) 0.98

The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut (2006) 0.98

Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep (2006) 0.98

Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology (2005) 0.98

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Lung Cancer (2004) 0.98

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci (2009) 0.98

Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem (2005) 0.97

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer (2013) 0.97

Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol (2005) 0.97

Chop-deficient mice showed increased adiposity but no glucose intolerance. Obesity (Silver Spring) (2007) 0.97

Liver X receptor-alpha gene expression is positively regulated by thyroid hormone. Endocrinology (2007) 0.97

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology (2009) 0.96

Rapid gastric emptying, rather than delayed gastric emptying, might provoke functional dyspepsia. J Gastroenterol Hepatol (2011) 0.96

Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun (2010) 0.96

Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. J Cell Physiol (2010) 0.96

Monosodium L-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying. Am J Clin Nutr (2008) 0.95

Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology (2009) 0.95

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? Int J Clin Oncol (2007) 0.95

Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. Endocrinology (2005) 0.95

Extracellular acidification stimulates IL-6 production and Ca(2+) mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.95

Syntaxin 4 and Synip (syntaxin 4 interacting protein) regulate insulin secretion in the pancreatic beta HC-9 cell. J Biol Chem (2003) 0.95

The role of CHOP messenger RNA expression in the link between oxidative stress and apoptosis. Metabolism (2008) 0.94

Rac1 negatively regulates lipopolysaccharide-induced IL-23 p19 expression in human macrophages and dendritic cells and NF-kappaB p65 trans activation plays a novel role. J Immunol (2006) 0.94

Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene (2003) 0.94

Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci (2007) 0.94

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. Int J Oncol (2007) 0.93

A case of thymic enlargement in hyperthyroidism in a young woman. Thyroid (2004) 0.93

Interstrain differences in susceptibility to non-alcoholic steatohepatitis. J Gastroenterol Hepatol (2007) 0.93

The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia. Transpl Int (2006) 0.93

Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer. Jpn J Clin Oncol (2005) 0.92

Increased activity and expression of phospholipase D2 in human colorectal cancer. Oncol Res (2003) 0.92

B-cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass. J Thorac Oncol (2008) 0.91

High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients. Tohoku J Exp Med (2006) 0.91

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathol Res Pract (2008) 0.91

Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer. Ann Surg Oncol (2010) 0.91